Your browser doesn't support javascript.
loading
Corrigendum to "D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats" [Eur. J. Pharmacol. 862 (2019) 172632].
Dutta, Aloke K; Santra, Soumava; Harutyunyan, Arman; Das, Banibrata; Lisieski, Michael J; Xu, Liping; Antonio, Tamara; Reith, Maarten E A; Perrine, Shane A.
Afiliação
  • Dutta AK; Wayne State University, Department of Pharmaceutical Sciences, Detroit, MI, 48202, USA. Electronic address: adutta@wayne.edu.
  • Santra S; Wayne State University, Department of Pharmaceutical Sciences, Detroit, MI, 48202, USA.
  • Harutyunyan A; Department of Psychiatry and Behavioral Neurosciences, School of Medicine, Wayne State University, USA.
  • Das B; Wayne State University, Department of Pharmaceutical Sciences, Detroit, MI, 48202, USA.
  • Lisieski MJ; Department of Psychiatry and Behavioral Neurosciences, School of Medicine, Wayne State University, USA.
  • Xu L; Wayne State University, Department of Pharmaceutical Sciences, Detroit, MI, 48202, USA.
  • Antonio T; New York University, Department of Psychiatry, New York, NY, 10016, USA.
  • Reith MEA; New York University, Department of Psychiatry, New York, NY, 10016, USA.
  • Perrine SA; Department of Psychiatry and Behavioral Neurosciences, School of Medicine, Wayne State University, USA.
Eur J Pharmacol ; 933: 175286, 2022 Oct 15.
Article em En | MEDLINE | ID: mdl-36167739
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article